NIH SBIR/STTR Niche Assessment Program (NAP), I-Corps at NIH, and NIH SBIR/STTR Commercialization Accelerator Program (CAP).

A cornerstone of the SBIR and STTR programs is helping companies move along the path of commercialization, with an emphasis on reducing technology risk and increasing the value proposition. HHS offers the I-Corps TM at NIH program and the Niche Assessment Program for Phase I awardees, and the Commercialization Accelerator Program (CAP) for Phase II awardees.

Technologies supported by these programs include a range of drug, device, diagnostic or behavioral interventions.